60 Degrees Pharmaceuticals, Inc. (SXTPW) SEC Filings — 2025
16 SEC filings for 60 Degrees Pharmaceuticals, Inc. (SXTPW) in 2025.
Filings
- 60 Degrees Pharma Widens Loss Despite Revenue Surge, Cash Influx — 10-Q · Nov 13, 2025
- 60 Degrees Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Oct 10, 2025
- 60 Degrees Pharmaceuticals Files 8-K — 8-K · Sep 9, 2025
- 60 Degrees Pharmaceuticals Enters and Terminates Agreements — 8-K · Sep 5, 2025
- 60 Degrees Pharma Proposes Reverse Split, Boosts Equity Plan — DEF 14A · Aug 27, 2025
- 60 Degrees Pharma Narrows Q2 Loss Amid R&D Cuts, Cash Up — 10-Q · Aug 13, 2025
- 60 Degrees Pharmaceuticals Files 8-K — 8-K · Jul 18, 2025
- 60 Degrees Pharma Files S-1 for Public Offering — S-1 · Jul 7, 2025
- 60 Degrees Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 15, 2025
- 60 Degrees Pharmaceuticals Files 8-K for Other Event — 8-K · Apr 9, 2025
- 60 Degrees Pharmaceuticals Files 2024 Annual Report — 10-K · Mar 27, 2025
- 60 Degrees Pharmaceuticals Files S-1 — S-1 · Feb 14, 2025
- 60 Degrees Pharmaceuticals Files 8-K — 8-K · Feb 6, 2025
- 60 Degrees Pharmaceuticals Files 8-K — 8-K · Jan 30, 2025
- 60 Degrees Pharmaceuticals Files 8-K — 8-K · Jan 28, 2025
- 60 Degrees Pharmaceuticals Files 8-K — 8-K · Jan 8, 2025